# Exin Therapeutics — YC W25 Landing Page Growth Score

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-w25/exin-therapeutics
Source observed: 2026-09-30T02:44:58.473Z
Last checked: 2026-10-20T07:28:52.639+00:00
Indexed: 2026-09-30T06:57:16.322+00:00

---

# Exin Therapeutics landing page growth score

We provide a Growth Score report for [Exin Therapeutics](https://www.exintherapeutics.com/), an AI discovery platform for neurotherapeutics. This report evaluates the landing page across trust, CTA, value propositions, mobile web, and information hierarchy.

The overall Growth Score is **41/100**, updated **September 22, 2026**. The weakest category is **Trust**, scored **32/100**.

[Back to YC W25](https://www.lazyweb.com/yc-w25) · [Fix Trust](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes)

## Ranking

1. [Verge Genomics — 72](https://www.lazyweb.com/growth-score/site/vergegenomics.com)
2. Exin Therapeutics — 41

## Category scores

| Category | Score |
| --- | ---: |
| [Trust](https://www.lazyweb.com/yc-w25/exin-therapeutics#gs-trust) | 32 |
| [CTA](https://www.lazyweb.com/yc-w25/exin-therapeutics#gs-cta) | 42 |
| [Value props](https://www.lazyweb.com/yc-w25/exin-therapeutics#gs-value_props) | 42 |
| [Mobile web](https://www.lazyweb.com/yc-w25/exin-therapeutics#gs-mobile_web) | 42 |
| [Information hierarchy](https://www.lazyweb.com/yc-w25/exin-therapeutics#gs-information_hierarchy) | 48 |

## Trust — 32/100, Poor

Trust concerns whether the landing page provides proof that the product is real, competent, and safe to try.

![Verge Genomics trust comparison](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/vergegenomics.com.jpg?v=2026-09-22T12%3A40%3A59.809%2B00%3A00)

| Company | Trust read |
| --- | --- |
| Exin Therapeutics | No visible trust signal identified. |
| Verge Genomics | “JUN 16 — Introducing vBx: Breakthrough Model for Precision Neurology” news banner |

### Trust ranking

1. [Verge Genomics — 44](https://www.lazyweb.com/growth-score/site/vergegenomics.com)
2. Exin Therapeutics — 32

Our **Proof section builder** helps choose proof signals and provides copy and placement for a stronger trust section. [Build proof section](https://www.lazyweb.com/backlog?site=exintherapeutics.com#opt-trust-signals)

## CTA — 42/100, Poor

This category considers CTA copy, size, verb, and cost-feel, including whether the primary CTA earns the click.

![Verge Genomics CTA comparison](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/vergegenomics.com.jpg?v=2026-09-22T12%3A40%3A59.809%2B00%3A00)

### Problems identified

- No CTA anywhere in the fold.
- Only navigation links and a scroll chevron are available.
- The headline makes a promise without providing a next step.

### CTA ranking

1. [Verge Genomics — 76](https://www.lazyweb.com/growth-score/site/vergegenomics.com)
2. Exin Therapeutics — 42

Our **CTA rewrite studio** generates primary and secondary CTA options grounded in Exin Therapeutics’s offer and visitor objections. [Rewrite this CTA](https://www.lazyweb.com/backlog?site=exintherapeutics.com#opt-cta-writing)

## Value props — 42/100, Poor

This category asks whether the title, subtitle, and hero sell the product’s true value.

### Exin Therapeutics headline

> “An AI discovery platform for neurotherapeutics”

### Working

- Names the AI and neuro category immediately.
- Uses a clean, single-message hero.
- Uses imagery that fits the neuroscience theme.

### Could improve

- States no outcome or differentiator.
- Has no specific subhead.
- Has an unattractive line break on mobile.

### Value-proposition ranking

1. [Verge Genomics — 72](https://www.lazyweb.com/growth-score/site/vergegenomics.com)
2. Exin Therapeutics — 42

## Mobile web — 42/100, Poor

This category evaluates the phone experience as a first-class version of the landing page.

![Mobile web annotations on the Exin Therapeutics capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/exintherapeutics.com-mobile.jpg?v=2026-09-22T12%3A35%3A31.424%2B00%3A00)

1. **Wrapped headline word:** “neurotherapeutics” breaks in the middle of the word, leaving a stranded “s” on its own line; the headline scales down poorly.
2. **Headline over light background:** White headline text sits on the pale left half of the image, reducing contrast and legibility.
3. **Oversized information badge:** A large Google Sites info button dominates the bottom-left corner without providing user value.

Our **Mobile fix plan** converts these findings into a prioritized implementation checklist. [View mobile fixes](https://www.lazyweb.com/backlog?site=exintherapeutics.com#opt-mobile-web)

## Information hierarchy — 48/100, Poor

This category evaluates whether the design helps or inhibits the page’s intended message.

![Information hierarchy annotations on the Exin Therapeutics capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/exintherapeutics.com.jpg?v=2026-09-22T12%3A35%3A31.424%2B00%3A00)

1. **Headline over busy texture:** Thin white type sits directly on high-contrast neural imagery; light patches erode legibility on the left.
2. **Six-link navigation row:** Every clickable element in the fold is an exit path of equal weight, with no visual priority.
3. **Faint navigation contrast:** Gray navigation labels on the dark neural background are barely legible, especially “Careers” and “Contact us.”

Our **Layout priority plan** turns these callouts into a sequenced page plan covering what to keep, move, merge, or remove. [View layout plan](https://www.lazyweb.com/backlog?site=exintherapeutics.com#opt-information-hierarchy)

## Competitors

Competitors are inferred from product, audience, and value proposition.

1. [Verge Genomics — vergegenomics.com — 72](https://www.lazyweb.com/growth-score/site/vergegenomics.com)
2. Exin Therapeutics — 41

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-w25%2Fexin-therapeutics&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-w25%2Fexin-therapeutics). Opening a form does not execute a tool.